RecruitingNCT06372613

Association Between LRG and Histologic Remission in Ulcerative Colitis

What is the Level of Serum Leucine-rich α 2-glycoprotein (LRG) Which Predicts Histologic Remission in Patients With Ulcerative Colitis?

Sponsor

Showa Inan General Hospital

Enrollment

100 participants

Start Date

Feb 25, 2024

Study Type

OBSERVATIONAL

Conditions

Ulcerative Colitis in Histologic Remission

Summary

We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed when histologic remission is predicted, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.

Eligibility

Min Age: 20 YearsMax Age: 90 Years

Inclusion Criteria1

active UC patients

Exclusion Criteria1

None

Locations(1)

Showa Inan General Hospital

Komagane, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06372613